Enhancement of LIN28B-induced hematopoietic reprogramming by IGF2BP3

Fetal hematopoietic stem and progenitor cells (HSPCs) hold promise to cure a wide array of hematological diseases, and we previously found a role for the RNA-binding protein (RBP) Lin28b in respecifying adult HSPCs to resemble their fetal counterparts. Here we show by single-cell RNA sequencing that...

Full description

Saved in:
Bibliographic Details
Published in:Genes & development Vol. 33; no. 15-16; pp. 1048 - 1068
Main Authors: Wang, Saifeng, Chim, Bryan, Su, Yijun, Khil, Pavel, Wong, Madeline, Wang, Xiantao, Foroushani, Amir, Smith, Patrick T, Liu, Xiuhuai, Li, Rui, Ganesan, Sundar, Kanellopoulou, Chrysi, Hafner, Markus, Muljo, Stefan A
Format: Journal Article
Language:English
Published: United States Cold Spring Harbor Laboratory Press 01-08-2019
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fetal hematopoietic stem and progenitor cells (HSPCs) hold promise to cure a wide array of hematological diseases, and we previously found a role for the RNA-binding protein (RBP) Lin28b in respecifying adult HSPCs to resemble their fetal counterparts. Here we show by single-cell RNA sequencing that Lin28b alone was insufficient for complete reprogramming of gene expression from the adult toward the fetal pattern. Using proteomics and in situ analyses, we found that Lin28b (and its closely related paralog, Lin28a) directly interacted with Igf2bp3, another RBP, and their enforced co-expression in adult HSPCs reactivated fetal-like B-cell development in vivo more efficiently than either factor alone. In B-cell progenitors, Lin28b and Igf2bp3 jointly stabilized thousands of mRNAs by binding at the same sites, including those of the B-cell regulators and as well as mRNA itself, forming an autoregulatory loop. Our results suggest that Lin28b and Igf2bp3 are at the center of a gene regulatory network that mediates the fetal-adult hematopoietic switch. A method to efficiently generate induced fetal-like hematopoietic stem cells (ifHSCs) will facilitate basic studies of their biology and possibly pave a path toward their clinical application.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work
ISSN:0890-9369
1549-5477
DOI:10.1101/gad.325100.119